Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(2.03)
# 1,514
Out of 4,412 analysts
184
Total ratings
28.5%
Success rate
-3.26%
Average return
Main Sectors:
Top Industries:
23 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DTIL Precision BioSciences | Reiterates: Buy | $60 | $9.84 | +509.76% | 10 | Apr 17, 2024 | |
| LBPH Longboard Pharmaceuticals | Reiterates: Buy | $60 | $21.23 | +182.62% | 8 | Apr 16, 2024 | |
| ATAI Atai Life Sciences | Maintains: Buy | $20 → $15 | $1.97 | +661.42% | 10 | Apr 3, 2024 | |
| ALT Altimmune | Maintains: Buy | $15 → $12 | $6.40 | +87.65% | 9 | Apr 1, 2024 | |
| IVVD Invivyd | Reiterates: Buy | $15 | $2.08 | +621.15% | 7 | Mar 25, 2024 | |
| MIST Milestone Pharmaceuticals | Reiterates: Buy | $25 | $1.57 | +1,492.36% | 9 | Mar 22, 2024 | |
| VYGR Voyager Therapeutics | Initiates: Buy | $30 | $7.77 | +286.10% | 1 | Mar 19, 2024 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $3 → $5 | $0.52 | +857.30% | 10 | Mar 19, 2024 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $21.88 | +242.78% | 11 | Mar 15, 2024 | |
| VIR Vir Biotechnology | Reiterates: Buy | $110 | $8.37 | +1,214.22% | 13 | Mar 15, 2024 | |
| MNMD Mind Medicine (MindMed) | Reiterates: Buy | $75 | $9.03 | +730.56% | 11 | Mar 14, 2024 | |
| CYBN Cybin | Maintains: Buy | $5 | $0.35 | +1,328.57% | 10 | Mar 13, 2024 | |
| ONCY Oncolytics Biotech | Maintains: Buy | $5 | $1.09 | +358.72% | 11 | Mar 8, 2024 | |
| GOSS Gossamer Bio | Reiterates: Buy | $10 | $0.70 | +1,336.16% | 6 | Mar 6, 2024 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $90 | $58.10 | +54.91% | 9 | Mar 6, 2024 | |
| ALNY Alnylam Pharmaceuticals | Reiterates: Buy | $395 | $147.36 | +168.05% | 15 | Mar 5, 2024 | |
| GHRS GH Research | Reiterates: Buy | $40 | $10.75 | +272.09% | 7 | Mar 4, 2024 | |
| CMPS COMPASS Pathways | Reiterates: Buy | $120 | $8.11 | +1,379.65% | 7 | Mar 1, 2024 | |
| QURE uniQure | Maintains: Buy | $30 → $25 | $4.39 | +469.48% | 6 | Mar 1, 2024 | |
| ARWR Arrowhead Pharmaceuticals | Reiterates: Buy | $90 | $23.13 | +289.11% | 9 | Feb 8, 2024 | |
| BNTC Benitec Biopharma | Maintains: Buy | $170 → $68 | $7.43 | +815.21% | 2 | Sep 23, 2022 | |
| ALLK Allakos | Maintains: Buy | $230 → $20 | $1.10 | +1,718.18% | 2 | Dec 28, 2021 | |
| MNDY monday.com | Maintains: Outperform | n/a | $192.80 | - | 1 | Aug 18, 2021 |
Precision BioSciences
Apr 17, 2024
Reiterates: Buy
Price Target: $60
Current: $9.84
Upside: +509.76%
Longboard Pharmaceuticals
Apr 16, 2024
Reiterates: Buy
Price Target: $60
Current: $21.23
Upside: +182.62%
Atai Life Sciences
Apr 3, 2024
Maintains: Buy
Price Target: $20 → $15
Current: $1.97
Upside: +661.42%
Altimmune
Apr 1, 2024
Maintains: Buy
Price Target: $15 → $12
Current: $6.40
Upside: +87.65%
Invivyd
Mar 25, 2024
Reiterates: Buy
Price Target: $15
Current: $2.08
Upside: +621.15%
Milestone Pharmaceuticals
Mar 22, 2024
Reiterates: Buy
Price Target: $25
Current: $1.57
Upside: +1,492.36%
Voyager Therapeutics
Mar 19, 2024
Initiates: Buy
Price Target: $30
Current: $7.77
Upside: +286.10%
Sangamo Therapeutics
Mar 19, 2024
Reiterates: Buy
Price Target: $3 → $5
Current: $0.52
Upside: +857.30%
Silence Therapeutics
Mar 15, 2024
Reiterates: Buy
Price Target: $75
Current: $21.88
Upside: +242.78%
Vir Biotechnology
Mar 15, 2024
Reiterates: Buy
Price Target: $110
Current: $8.37
Upside: +1,214.22%
Mind Medicine (MindMed)
Mar 14, 2024
Reiterates: Buy
Price Target: $75
Current: $9.03
Upside: +730.56%
Cybin
Mar 13, 2024
Maintains: Buy
Price Target: $5
Current: $0.35
Upside: +1,328.57%
Oncolytics Biotech
Mar 8, 2024
Maintains: Buy
Price Target: $5
Current: $1.09
Upside: +358.72%
Gossamer Bio
Mar 6, 2024
Reiterates: Buy
Price Target: $10
Current: $0.70
Upside: +1,336.16%
Immunocore Holdings
Mar 6, 2024
Reiterates: Buy
Price Target: $90
Current: $58.10
Upside: +54.91%
Alnylam Pharmaceuticals
Mar 5, 2024
Reiterates: Buy
Price Target: $395
Current: $147.36
Upside: +168.05%
GH Research
Mar 4, 2024
Reiterates: Buy
Price Target: $40
Current: $10.75
Upside: +272.09%
COMPASS Pathways
Mar 1, 2024
Reiterates: Buy
Price Target: $120
Current: $8.11
Upside: +1,379.65%
uniQure
Mar 1, 2024
Maintains: Buy
Price Target: $30 → $25
Current: $4.39
Upside: +469.48%
Arrowhead Pharmaceuticals
Feb 8, 2024
Reiterates: Buy
Price Target: $90
Current: $23.13
Upside: +289.11%
Benitec Biopharma
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $7.43
Upside: +815.21%
Allakos
Dec 28, 2021
Maintains: Buy
Price Target: $230 → $20
Current: $1.10
Upside: +1,718.18%
monday.com
Aug 18, 2021
Maintains: Outperform
Price Target: n/a
Current: $192.80
Upside: -